FDA Approves Alymsys (bevacizumab-maly), a Biosimilar to Avastin
Amneal Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s Biologics License Application (BLA) for bevacizumab-maly, a biosimilar referenci...